Medical Device Partnering Program (MDPP Victoria) drop-in sessions

11 September 2019 Calling all Victorian-based stakeholders! Keep an eye out as the Medical Device Partnering Program (MDPP) will be in your neighbourhood! Drop-In sessions will run for the next few weeks as part of our ongoing strategy to…

Read More

Collaboration Agreement signed between GTG and The Translational Genomics Research Institute (TGen) of Phoenix, Arizona USA

24 September 2019 Genetic Technologies Limited (“Company”), a provider of world-leading genetic risk assessment test products today announced that it has signed a 3-year Collaboration Agreement with TGen. TGen, an affiliate of City of Hope in Duarte, California,…

Read More

Pharmaceutical and Medtech Export Growth Soars

23 September 2019 Minister for Jobs, Innovation and Trade Victoria’s medtech and pharmaceutical sector is booming, with new data released today showing that support from the Andrews Labor Government has fuelled exceptional export growth. A report by ACIL…

Read More

Immutep to receive £4M milestone payment from GSK

23 September 2019 Sydney, Australia – Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep“ or “the Company”), a biotechnology company developing novel immunotherapy treatments for cancer and autoimmune diseases, announces that it will receive a milestone payment from GSK…

Read More

The PoC (Point of Care) is not where it used to be…

19 September In the US, the shift in where care is rendered is practically seismic. Almost overnight it seems (5 years in real world terms), retail clinics have become an important part of primary care and convenience is…

Read More

Victorian Government News

18 September 2019 The Hon Martin Pakula, Minister for Jobs, Innovation and Trade, recently attended the kick-off of the Medtech Actuator’s first national sprint meeting and engaged with the MedTech Actuator Accelerator Program’s fourth cohort. Following the Minister’s…

Read More

Delivering Value To Our Members – ARMI

17 September 2019 When the Australian Regenerative Medicine Institute at Monash University needed help to boost industry awareness of its work and interact with the growing regenerative medicine sector, the BioMelbourne Network helped with contacts and hosted a…

Read More

Monash University students helping to reduce the spread of mosquito-borne disease

17 September 2019 A Monash University student has spent five weeks conducting immersive research at the World Mosquito Program’s (WMP) Fiji site. Fiji experiences regular bouts of vector-borne disease and the program has operated there since 2018. Tanaya…

Read More

AdAlta secures licensing deal for the i-body platform with global medical technology and diagnostics firm, GE Healthcare

16 September 2019 Melbourne Australia: AdAlta Limited (ASX:1AD), today announced it has signed a commercial agreement for its i-body platform with global medical technology firm, GE Healthcare. Financial terms were not disclosed. The licensing deal will see the…

Read More

European Union Regulatory Certification and MRSA Study Results: APAS® Independence available for sale in European Union

16 September 2019 Adelaide, Australia: Australian medical technology company LBT Innovations Limited (ASX: LBT) (LBT or the Company), a leader in medical technology automation using artificial intelligence, is pleased to announce that the Conformité Européene or CE Mark…

Read More

Cyber Attacks: Why Biotech, Life Sciences & Healthcare organisations fall victim to cybercrime & what you can do about it

16 September 2019 Our industry is under attack – there is no doubt about it! The news of yet another organization falling victim to cybercrime has become a daily occurrence. As long as there is a promise of…

Read More

DEP® irinotecan synergistic with Lynparza® in refractory human colon cancer model

12 September 2019 Melbourne, Australia: Starpharma today announced that its patented clinical stage nanoparticle formulation, DEP® irinotecan, showed significantly enhanced efficacy benefits over standard irinotecan (Camptosar®) and olaparib (Lynparza®) alone and in combination, in an irinotecan-refractory HT-29 human colon cancer…

Read More

Home

News & opinion

Member Directory

Events